GPNMB has also been identified as a biomarker in CSF for neuropathic forms of Gaucher’s disease (types 2 and 3) (Zigdon et al. 2015) that are caused by mutations in GBA, a Parkinson’s disease-associated gene (Siebert et al. 2014). This evidence concerns the gene GPNMB and Gaucher disease.